Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer
Clinical trial NCT00780000 · TERMINATED
Trial details
- NCT number
- NCT00780000
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.